- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Portus Wealth Advisors LLC Buys $1.05M Stake in Johnson & Johnson
The investment firm added over 5,600 shares of the healthcare giant to its portfolio in the third quarter.
Mar. 19, 2026 at 9:13am
Got story updates? Submit your updates here. ›
Portus Wealth Advisors LLC, a financial advisory firm, disclosed in a regulatory filing that it purchased a new stake of 5,658 shares in Johnson & Johnson (NYSE: JNJ) during the third quarter of 2022. The position was valued at approximately $1.05 million, making it the 29th largest holding in Portus Wealth Advisors' portfolio.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a presence across pharmaceuticals, medical devices, and consumer products. The investment by Portus Wealth Advisors suggests the firm sees long-term growth potential in J&J's business, which could signal broader investor confidence in the company's outlook.
The details
According to the 13F filing, Portus Wealth Advisors purchased the 5,658 shares of J&J stock during the third quarter of 2022. The position represents approximately 1% of the firm's total investment portfolio. J&J is known for its stable dividend payments and diversified revenue streams, which likely appealed to the wealth management firm's investment strategy.
- Portus Wealth Advisors disclosed the new J&J stake in its 13F filing for the third quarter of 2022.
The players
Portus Wealth Advisors LLC
A financial advisory firm that manages investments for individual and institutional clients.
Johnson & Johnson (NYSE: JNJ)
A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.
The takeaway
Portus Wealth Advisors' investment in Johnson & Johnson reflects the healthcare giant's reputation as a stable, dividend-paying stock with diversified revenue streams. The purchase suggests the firm sees long-term growth potential in J&J's business, which could signal broader investor confidence in the company's outlook.
